China NMPA Product Recall - DreamStation Auto CPAP (CNX500S17) Instrument

On May 8, 2020, Philips (China) Investment Co., Ltd. announced a voluntary Class III recall for specific batches of its DreamStation Auto CPAP (CNX500S17) ventilators. This regulatory action, overseen by the National Medical Products Administration (NMPA), was prompted by the company's finding that the product did not meet established standards. The primary issue identified was a missing fresh gas inlet label on the affected devices. This labeling deficiency presented a non-compliance with product specifications, necessitating corrective action to maintain product integrity and ensure user safety. Under the regulatory oversight of the NMPA, Philips (China) Investment Co., Ltd. is undertaking this recall to rectify the identified manufacturing inconsistency. The Class III designation indicates that while the issue is not likely to cause serious adverse health consequences, it still warrants corrective measures. The required action involves the removal of the non-compliant devices from the market, with detailed information regarding the specific models, specifications, and batch numbers provided in the accompanying "Medical Device Recall Event Report Form." This initiative underscores the company's commitment to product quality and adherence to NMPA's medical device regulations.